Fengjun Cao

机构：Hubei University of Medicine · ORCID：0000-0002-0494-3474

发表论文 34 篇 · 总被引 426 次 · h-index 9

代表论文

• Hydroxychloroquine induced lung cancer suppression by enhancing chemo-sensitization and promoting the transition of M2-TAMs to M1-like macrophages (2018 · Journal of Experimental & Clinical Cancer Research · 被引 142)
• Diagnostic value of miR-193a-3p in Alzheimer's disease and miR-193a-3p attenuates amyloid-β induced neurotoxicity by targeting PTEN (2019 · Experimental Gerontology · 被引 53)
• GPX2 overexpression indicates poor prognosis in patients with hepatocellular carcinoma (2017 · Tumor Biology · 被引 41)
• Downregulation of RIG-I mediated by ITGB3/c-SRC/STAT3 signaling confers resistance to interferon-α-induced apoptosis in tumor-repopulating cells of melanoma (2020 · Journal for ImmunoTherapy of Cancer · 被引 39)
• Weighted gene co-expression network-based approach to identify key genes associated with anthracycline-induced cardiotoxicity and construction of miRNA-transcription factor-gene regulatory network (2021 · Molecular Medicine · 被引 24)
• High C-Reactive Protein to Albumin Ratio Predicts Inferior Clinical Outcomes in Extranodal Natural Killer T-Cell Lymphoma (2020 · Dose-Response · 被引 11)